Lazard Capital Downgrades Amgen (AMGN) to Sell
Tweet Send to a FriendGet Alerts AMGN Hot Sheet
Price: $104.24 +2.02%
Rating Summary:
12 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
12 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade AMGN Now!
Lazard Capital downgraded Amgen (NASDAQ: AMGN) from Neutral to Sell with a price target of $58.00.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $69.28 yesterday, with a 52 week range of $47.66-$70.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $69.28 yesterday, with a 52 week range of $47.66-$70.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- UPDATE: Sidoti Downgrades Texas Industries (TXI) to Neutral
- Jefferies Downgrades First Republic Bank (FRC) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Lazard
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
